Ethyl methyl hydroxypyridine succinate + Meldonium

DRUG2 trials

Sponsors

Promomed, LLC

Conditions

AstheniaCOVID-19Cognitive ImpairmentFunctional MRI

Phase 4

Safety and Efficacy of the Therapy With BRAINMAX® for the Treatment of Patients With Asthenia After COVID-19

CompletedNCT05689827

Promomed, LLCAsthenia, COVID-19

Start: 2022-04-05End: 2022-11-10Updated: 2023-07-13

Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19

CompletedNCT05939622

Promomed, LLCAsthenia, Cognitive Impairment, COVID-19 +1

Start: 2022-05-18End: 2022-12-20Updated: 2023-07-13